APA (7th ed.) Citation

Harter, P., & Marmé, F. (2025). Targeting the glucocorticoid receptor in relapsed ovarian cancer: A new pathway and standard treatment option in ovarian cancer : comment. The lancet, 405(10496), . https://doi.org/10.1016/S0140-6736(25)01151-1

Chicago Style (17th ed.) Citation

Harter, Philipp, and Frederik Marmé. "Targeting the Glucocorticoid Receptor in Relapsed Ovarian Cancer: A New Pathway and Standard Treatment Option in Ovarian Cancer : Comment." The Lancet 405, no. 10496 (2025). https://doi.org/10.1016/S0140-6736(25)01151-1.

MLA (9th ed.) Citation

Harter, Philipp, and Frederik Marmé. "Targeting the Glucocorticoid Receptor in Relapsed Ovarian Cancer: A New Pathway and Standard Treatment Option in Ovarian Cancer : Comment." The Lancet, vol. 405, no. 10496, 2025, https://doi.org/10.1016/S0140-6736(25)01151-1.